This Primer on Opioid-related Public Health Emergencies provides key information and visual snapshots of federal, state, tribal, and local emergency declarations in response to the opioid crisis across the U.S.
Prescription Drug Monitoring Programs (PDMPs) can help clinicians improve decisions regarding opioid prescribing. However, since state laws and regulations governing access to these systems often apply only to providers licensed in the states in which the PDMP is located, and many federal health care workers are not so licensed, many federal providers are not subject to requirements. This fact sheet outlines the policies of the three federal health care institutions with regard to the use of PDMPs when prescribing opioids.
Indiana has modified its law to increase access to the opioid overdose reversing medication naloxone by making the medication easier to access and encouraging individuals who obtain naloxone to summon emergency assistance in the event of an overdose. The law’s provisions, however, are less supportive of those activities than similar laws in many states.
In the rapidly shifting contours of the opioid crisis, it is vital that governments, clinicians and the public have access to timely, comprehensive data on overdose deaths. Unfortunately, such data are rarely available. A handful of states have established bodies that specifically review overdose deaths to provide additional data and, typically, make recommendations for policy improvements. This brief explains and contrasts the specifics of panels in the six states that have established them.
High rates of morbidity and mortality among Americans related to opioid use have lead multiple jurisdictions to declare a formal state of emergency and public health emergency. Declaring a state of emergency grants states and localities additional resources to address the epidemic immediately. This Fact Sheet provides a brief summary of the emergency declarations in six states, and the Primer provides a visual snapshot and synopses of state-and tribal-based emergency declarations across the U.S. based on currently-available information.
Some local and municipal governments have enacted mandatory local drug take-back programs, also called Extended Producer Responsibility (EPR) or stewardship programs that are funded and managed by pharmaceutical companies or producers. This issue brief provides and overview of mandatory drug take-back programs in the U.S.
As powerful synthetic opioids become more available, it is imperative that health departments and other relevant actors are provided with accurate, timely and actionable information on both fatal and non-fatal overdose. This fact sheet provides a snapshot of current and proposed laws, regulations and sub-regulatory sources governing mandatory disease reporting.
Tuesday, September 19 from 1 – 2:30 p.m. (ET). The relentless toll of the opioid epidemic has prompted six states to declare formal states of emergency. In August the White House Commission on Combating Drug Addiction and the Opioid Crisis recommended that President Trump declare a national public emergency, which he promised to do. This webinar examines emergency declarations and their potential impact as well as possible drawbacks.
It is estimated that 15,000 deaths each year are caused by opioid overdose. These overdoses are typically reversible through the timely administration of the drug naloxone and the provision of emergency care. In an attempt to reverse this increase in preventable overdose deaths, many states have recently amended older laws to increase access to emergency care for opiate overdose and encourage those who assist a person experiencing an overdose.
Thursday, July 27 at 2:00 p.m. ET. This webinar will provide an overview of what states are currently doing to address the epidemic, along with a discussion of those laws and policies that might better equip them to confront this growing public health crisis. View the playback.